Zai Lab Partner argenx Announces U.S. Food and Drug Administration (FDA) Approval of VYVGART™ … | Your Money
VYVGART is the primary and solely FDA-approved neonatal Fc receptor blocker68% ofanti-acetylcholine receptor (AChR) antibody positivegMG sufferers handled with VYVGART ...
